Jove
Visualize
Contact Us

Related Experiment Videos

Trimethoprim/sulfamethoxazole desensitization

L M Cortese1, D M Soucy, T P Endy

  • 1Henry M Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Medical Center, Washington, DC, USA.

The Annals of Pharmacotherapy
|February 1, 1996
PubMed
Summary

This study explores trimethoprim/sulfamethoxazole (TMP/SMX) desensitization for patients with AIDS. Protocols involve gradual dose increases, with careful monitoring for allergic reactions and adherence to medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus.

The American journal of tropical medicine and hygiene·2007
Same author

Laboratory transmission of Japanese encephalitis and West Nile viruses by molestus form of Culex pipiens (Diptera: Culicidae) collected in Uzbekistan in 2004.

Journal of medical entomology·2006
Same author

Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys.

Antimicrobial agents and chemotherapy·2005
Same author

Experimental transmission of Karshi and Langat (tick-borne encephalitis virus complex) viruses by Ornithodoros ticks (Acari: Argasidae).

Journal of medical entomology·2004
Same author

Molecular serotyping of dengue viruses in field-caught Aedes mosquitos by in-house RNA extraction/RT-PCR reagent kits.

The Southeast Asian journal of tropical medicine and public health·2003
Same author

First documented outbreak of hepatitis E virus transmission in Java, Indonesia.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Pneumocystis pneumonia (PCP) treatment in patients with AIDS is limited.
  • Trimethoprim/sulfamethoxazole (TMP/SMX) desensitization is crucial for AIDS patients with sulfa allergies.
  • Established guidelines for TMP/SMX desensitization are lacking.

Purpose of the Study:

  • To review and discuss various successful TMP/SMX desensitization protocols.
  • To highlight the importance of individualized dosing based on allergic reaction severity.
  • To emphasize the need for ongoing patient monitoring and medication compliance.

Main Methods:

  • Review of described desensitization protocols.
  • Dosing strategies include small successive daily doses or one small daily dose.

Related Experiment Videos

  • Severity of allergic reaction guides regimen selection.
  • Protocols involve slow titration from low to full therapeutic doses.

    • Main Results:

    • Successful desensitization protocols exist, though guidelines are absent.
    • Slow titration with low initial doses appears efficacious.
    • Continued monitoring is necessary as sensitivity may recur.
    • Alternative therapy may be continued during desensitization.

    Conclusions:

    • TMP/SMX desensitization is a viable option for AIDS patients with sulfa allergies.
    • Careful patient evaluation and discussion of risks (e.g., Stevens-Johnson syndrome, anaphylaxis) are essential.
    • Further studies are needed to establish efficacy and specific dosing guidelines.